Meyka Pro banner
Omnicell, Inc.

Omnicell, Inc. (OMCL) Stock Overview

Explore Omnicell, Inc.’s financial performance, market position, analyst ratings, and future outlook.

OMCLNASDAQ
HealthcareMedical - Equipment & Services
$36.81
$0.65(1.80%)
U.S. Market opens in 49h 50m

Omnicell, Inc. (OMCL)

Meyka AI Score

Z

Key Financials

Market Cap1.7B
P/E Ratio43.50
EPS (TTM)$1.91
ROE0.03%
Fundamental Analysis

AI Price Forecasts

1 Month$45.20
3 Months$52.18
1 Year Target$42.37

OMCL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Omnicell, Inc. (NASDAQ: OMCL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Omnicell, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of OMCL on the NASDAQ shows an RSI of 38.44, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $42.37 for the NASDAQ listing.

Key metrics behind Omnicell, Inc.'s NASDAQ-traded stock include a P/E ratio of 43.50 and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of OMCL on the NASDAQ.

Price Performance (NASDAQ: OMCL)

1-Day Change
1.80%
5-Day Change
0.71%
1-Month Change
-17.02%
3-Month Change
-15.05%
6-Month Change
-0.70%
Year-to-Date (YTD) Change
-18.74%
1-Year Change
18.63%
3-Year Change
-43.60%
5-Year Change
-75.80%
All-Time (Max) Change
320.21%

Contact Information

650 251 6100
4220 North Freeway, Fort Worth, TX, 76137

Company Facts

35,800 Employees
IPO DateAug 7, 2001
CountryUS
Actively Trading

Frequently Asked Questions